Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03623165 · ClinicalTrials.gov registry record
PRODIGY Registry in NYHA Class III Heart Failure Patients
A clinical trial, sponsored by Endotronix.
- Terminated
- Registry status
- 7
- Enrollment target
NCT03623165 is a clinical trial that was terminated before completion, run by Endotronix. The registered enrollment target is 7 participants.
The verdict
NCT03623165 was terminated before completion, sponsored by Endotronix.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is an observational, prospective, single arm, multi-center registry to evaluate the Cordella™ Heart Failure System (CHFS) in up to 250 NYHA Class III HF patients .
Interventions
- DEVICE Cordella™ Heart Failure System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03623165
The ClinicalTrials.gov registry entry for NCT03623165 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endotronix, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cordella™ Heart Failure System is the first listed.
NCT03623165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03623165 about?
NCT03623165 is a clinical study titled "PRODIGY Registry in NYHA Class III Heart Failure Patients". This is an observational, prospective, single arm, multi-center registry to evaluate the Cordella™ Heart Failure System (CHFS) in up to 250 NYHA Class III HF patients .
What is the current status of trial NCT03623165?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2018-08-01. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT03623165?
The interventions under investigation include: Cordella™ Heart Failure System (DEVICE).
Who is sponsoring clinical trial NCT03623165?
This trial is sponsored by Endotronix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.